Prognostic value of systemic inflammation indices in patients with metastatic colorectal cancer treated with TAS-102: a single-center retrospective real-world study
{{output}}
Background: While the efficacy of trifluridine/tipiracil (TAS-102) in late-line metastatic colorectal cancer (mCRC) is established in clinical trials, real-world predictive and prognostic factors remain poorly characterized. This... ...
